Table of Content
1.Executive summary
- Global Uveitis Treatment Market Introduction
2.1. Global Uveitis Treatment Market – Taxonomy
2.2. Global Uveitis Treatment Market –Definitions
2.2.1. Drug Class Type
2.2.2. Disease Type
2.2.3. Cause
2.2.4. Distribution Channel
- Global Uveitis Drugs Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Uveitis Treatment Market Dynamics – Factors Impact Analysis
3.6. Global Uveitis Treatment Market – Regulations
3.6.1. U.S
3.6.2. Europe
3.6.3. Japan
3.6.4. China
3.7. Global Uveitis Treatment Market – Product Innovations
- Global Uveitis Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
4.3. Market Oppurtunity Analysis
- Global Uveitis Treatment Market, By Drug Class, 2013 – 2017 and Forecast, 2018 – 2024
5.1. Corticosteroids
5.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.1.3. Market Opportunity Analysis
5.2. Immunosuppressant
5.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.2.3. Market Opportunity Analysis
5.3. Monoclonal antibodies
5.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.3.3. Market Opportunity Analysis
5.4. Antibiotics
5.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.4.3. Market Opportunity Analysis
5.5. Antivirals
5.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.5.3. Market Opportunity Analysis
5.6. Antifungal
5.6.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.6.3. Market Opportunity Analysis
5.7. Analgesics
5.7.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.7.3. Market Opportunity Analysis
- Global Uveitis Treatment Market Forecast, By Disease Type, 2013 – 2017 and Forecast, 2018 – 2024
6.1. Anterior Uveitis
6.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.1.3. Market Opportunity Analysis
6.2. Posterior Uveitis
6.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.2.3. Market Opportunity Analysis
6.3. Intermediate Uveitis
6.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.3.3. Market Opportunity Analysis
6.4. Panuveitis
6.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.4.3. Market Opportunity Analysis
- Global Uveitis Drugs Market Forecast, By Cause, 2013 – 2017 and Forecast, 2018 – 2024
7.1. Infectious Uveitis
7.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.1.3. Market Opportunity Analysis
7.2. Non-Infectious Uveitis
7.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.2.3. Market Opportunity Analysis
- Global Uveitis Treatment Market Forecast, By Distribution Channel, 2013 – 2017 and Forecast, 2018 – 2024
8.1. Hospital Pharmacies
8.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.1.3. Market Opportunity Analysis
8.2. Retail Pharmacies
8.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.2.3. Market Opportunity Analysi
8.3. Others
8.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.3.3. Market Opportunity Analysis
- Global Uveitis Treatment Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024
9.1. North America
9.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.5.3. Market Opportunity Analysis
9.6. Global Uveitis Treatment Market – Opportunity Analysis Index, By Drug Class Type, By Disease Type, Cause, Distribution Channel, and Region, 2018 – 2024
- North America Uveitis Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
10.1.1. Drug Class Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1.1. Corticosteroids
10.1.1.2. Immunosuppressant
10.1.1.3. Monoclonal antibodies
10.1.1.4. Antibiotics
10.1.1.5. Antivirals
10.1.1.6. Antifungal
10.1.1.7. Analgesics
10.1.2. Disease Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.2.1. Anterior Uveitis
10.1.2.2. Posterior Uveitis
10.1.2.3. Intermediate Uveitis
10.1.2.4. Panuveitis
10.1.3. Cause Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.3.1. Infectious Uveitis
10.1.3.2. Non Infectious Uveitis
10.1.4. Distribution Channel Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.4.1. Hospital Pharmacies
10.1.4.2. Retail Pharmacies
10.1.4.3. Others
10.1.5. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.1.5.1. U.S.
10.1.5.2. Canada
10.1.6. North America Uveitis Treatment Market – Opportunity Analysis Index, By Drug Class, Disease Type, Cause, Distribution Channel and Country, 2018 – 2024
10.1.7. North America Uveitis Treatment Market Dynamics – Trends
- Europe Uveitis Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
11.1.1. Drug Class Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1.1. Corticosteroids
11.1.1.2. Immunosuppressant
11.1.1.3. Monoclonal antibodies
11.1.1.4. Antibiotics
11.1.1.5. Antivirals
11.1.1.6. Antifungal
11.1.1.7. Analgesics
11.1.2. Disease Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.2.1. Anterior Uveitis
11.1.2.2. Posterior Uveitis
11.1.2.3. Intermediate Uveitis
11.1.2.4. Panuveitis
11.1.3. Cause Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.3.1. Infectious Uveitis
11.1.3.2. Non Infectious Uveitis
11.1.4. Distribution Channel Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.4.1. Hospital Pharmacies
11.1.4.2. Retail Pharmacies
11.1.4.3. Others
11.1.5. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.5.1. Germany
11.1.5.2. UK
11.1.5.3. France
11.1.5.4. Spain
11.1.5.5. Italy
11.1.5.6. Russia
11.1.5.7. Poland
11.1.5.8. Rest of Europe
11.1.6. Europe Uveitis Treatment Market – Opportunity Analysis Index, By Drug Class, Disease Type, Cause, Distribution Channel and Country, 2018 – 2024
11.1.7. Europe Uveitis Treatment Market Dynamics – Trends
- Asia-Pacific Uveitis Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
12.1.1. Drug Class Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1.1. Corticosteroids
12.1.1.2. Immunosuppressant
12.1.1.3. Monoclonal antibodies
12.1.1.4. Antibiotics
12.1.1.5. Antivirals
12.1.1.6. Antifungal
12.1.1.7. Analgesics
12.1.2. Disease Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.2.1. Anterior Uveitis
12.1.2.2. Posterior Uveitis
12.1.2.3. Intermediate Uveitis
12.1.2.4. Panuveitis
12.1.3. Cause Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.3.1. Infectious Uveitis
12.1.3.2. Non Infectious Uveitis
12.1.4. Distribution Channel Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.4.1. Hospital Pharmacies
12.1.4.2. Retail Pharmacies
12.1.4.3. Others
12.1.5. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
12.1.5.1. Japan
12.1.5.2. China
12.1.5.3. India
12.1.5.4. ASEAN
12.1.5.5. Australia & New Zealand
12.1.5.6. Rest of Asia-Pacific
12.1.6. Asia-Pacific Uveitis Treatment Market – Opportunity Analysis Index, By Drug Class, Disease Type, Cause, Distribution Channel and Country, 2018 – 2024
12.1.7. Europe Uveitis Treatment Market Dynamics – Trends
- Latin America Uveitis Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
13.1.1. Drug Class Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1.1. Corticosteroids
13.1.1.2. Immunosuppressant
13.1.1.3. Monoclonal antibodies
13.1.1.4. Antibiotics
13.1.1.5. Antivirals
13.1.1.6. Antifungal
13.1.1.7. Analgesics
13.1.2. Disease Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.2.1. Anterior Uveitis
13.1.2.2. Posterior Uveitis
13.1.2.3. Intermediate Uveitis
13.1.2.4. Panuveitis
13.1.3. Cause Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.3.1. Infectious Uveitis
13.1.3.2. Non Infectious Uveitis
13.1.4. Distribution Channel Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.4.1. Hospital Pharmacies
13.1.4.2. Retail Pharmacies
13.1.4.3. Others
13.1.5. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.5.1. Brazil
13.1.5.2. Mexico
13.1.5.3. Argentina
13.1.5.4. Venezuela
13.1.5.5. Rest of Latin America
13.1.6. Latin America Uveitis Treatment Market – Opportunity Analysis Index, By Drug Class, Disease Type, Cause, Distribution Channel and Country, 2018 – 2024
13.1.7. Latin America Uveitis Treatment Market Dynamics – Trends
- Middle East and Africa Uveitis Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
14.1.1. Drug Class Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1.1. Corticosteroids
14.1.1.2. Immunosuppressant
14.1.1.3. Monoclonal antibodies
14.1.1.4. Antibiotics
14.1.1.5. Antivirals
14.1.1.6. Antifungal
14.1.1.7. Analgesics
14.1.2. Disease Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.2.1. Anterior Uveitis
14.1.2.2. Posterior Uveitis
14.1.2.3. Intermediate Uveitis
14.1.2.4. Panuveitis
14.1.3. Cause Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.3.1. Infectious Uveitis
14.1.3.2. Non Infectious Uveitis
14.1.4. Distribution Channel Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.4.1. Hospital Pharmacies
14.1.4.2. Retail Pharmacies
14.1.4.3. Others
14.1.5. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.5.1. Gulf Cooperation Council (GCC) Countries
14.1.5.2. Israel
14.1.5.3. South Africa
14.1.5.4. Rest of MEA
14.1.6. MEA Uveitis Treatment Market – Opportunity Analysis Index, By Drug Class, Disease Type, Cause, Distribution Channel and Country, 2018 – 2024
14.1.7. MEA Uveitis Treatment Market Dynamics – Trends
- Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. AbbVie Inc. (U.S.)
15.2.2. Eyegate Pharmaceuticals Inc. (U.S.)
15.2.3. Valeant Pharmaceuticals (Bausch + Lomb) (Canada)
15.2.4. Novartis AG (Switzerland)
15.2.5. Alimera Sciences Inc. (U.S.)
15.2.6. Santen Pharmaceutical Co. Ltd (Japan)
- Research Methodology
- Key Assumptions and Acronyms